Debt-to-equity of GoodRx Holdings, Inc. from 30 Jun 2021 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
GoodRx Holdings, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2021 to 30 Sep 2025.
  • GoodRx Holdings, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 103%, a 8.6% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

GoodRx Holdings, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 103% -10% -8.6% 30 Sep 2025
Q2 2025 97% -14% -13% 30 Jun 2025
Q1 2025 101% -2% -2.3% 31 Mar 2025
Q4 2024 108% +12% +13% 31 Dec 2024
Q3 2024 113% +19% +21% 30 Sep 2024
Q2 2024 112% +17% +18% 30 Jun 2024
Q1 2024 103% +7% +7.3% 31 Mar 2024
Q4 2023 96% 0% -0.39% 31 Dec 2023
Q3 2023 94% -2% -2.1% 30 Sep 2023
Q2 2023 95% +1% +1.2% 30 Jun 2023
Q1 2023 96% +3% +3.5% 31 Mar 2023
Q4 2022 96% +2% +2.2% 31 Dec 2022
Q3 2022 96% -2% -2% 30 Sep 2022
Q2 2022 94% -8% -7.5% 30 Jun 2022
Q1 2022 93% 31 Mar 2022
Q4 2021 94% 31 Dec 2021
Q3 2021 97% 30 Sep 2021
Q2 2021 101% 30 Jun 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.